Complement production and regulation by dendritic cells: Molecular switches between tolerance and immunity

Molecular Immunology

Volumn 45, Issue 16, 2008, Pages 4064-4072

  van Kooten, Cees ^a   Fiore, Nicoletta ^b   Trouw, Leendert A ^a   Csomor, Eszter ^a   Xu, Wei ^a   Castellano, Giuseppe ^b   Daha, Mohamed R ^a   Gelderman, Kyra A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

C1q; C3; Complement; Dendritic cells; Macrophages

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3;

ANIMAL; BIOLOGICAL MODEL; DENDRITIC CELL; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MACROPHAGE; REVIEW;

ANIMALS; COMPLEMENT C1Q; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNITY; MACROPHAGES; MODELS, IMMUNOLOGICAL;

EID: 55949130425     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.07.015     Document Type: Review

References (103)

1. Akira, S., Takeda, K., Kaisho, T., 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680.
2. Armbrust, T., Nordmann, B., Kreissig, M., Ramadori, G., 1997. C1Q synthesis by tissue mononuclear phagocytes from normal and from damaged rat liver: up-regulation by dexamethasone, down-regulation by interferon gamma, and lipopolysaccharide. Hepatology 26, 98-106.
3. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B., Palucka, K., 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
4. Banchereau, J., Steinman, R.M., 1998. Dendritic cells and the control of immunity. Nature 392, 245-252.
5. Berger, S.P., Roos, A., Mallat, M.J., Fujita, T., De Fijter, J.W., Daha, M.R., 2005. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am. J. Transplant. 5, 1361-1366.
6. Berger, S.P., Roos, A., Mallat, M.J., Schaapherder, A.F., Doxiadis, I.I., van Kooten, C., Dekker, F.W., Daha, M.R., De Fijter, J.W., 2007. Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J. Am. Soc. Nephrol. 18, 2416-2422.
7. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., Kuchroo, V.K., 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238.
8. Biswas, S.K., Gangi, L., Paul, S., Schioppa, T., Saccani, A., Sironi, M., Bottazzi, B., Doni, A., Vincenzo, B., Pasqualini, F., Vago, L., Nebuloni, M., Mantovani, A., Sica, A., 2006. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 107, 2112-2122.
9. Botto, M., Dell'Agnola, C., Bygrave, A.E., Thompson, E.M., Cook, H.T., Petry, F., Loos, M., Pandolfi, P.P., Walport, M.J., 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19, 56-59.
10. Bouwman, L.H., Roos, A., Terpstra, O.T., de, K.P., van, H.B., Verspaget, H.W., Berger, S.P., Daha, M.R., Frolich, M., van der Slik, A.R., Doxiadis, I.I., Roep, B.O., Schaapherder, A.F., 2005. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 129, 408-414.
11. Brown, K.M., Kondeatis, E., Vaughan, R.W., Kon, S.P., Farmer, C.K., Taylor, J.D., He, X., Johnston, A., Horsfield, C., Janssen, B.J., Gros, P., Zhou, W., Sacks, S.H., Sheerin, N.S., 2006. Influence of donor C3 allotype on late renal-transplantation outcome. N. Engl. J. Med. 354, 2014-2023.
12. Bultink, I.E., Hamann, D., Seelen, M.A., Hart, M.H., Dijkmans, B.A., Daha, M.R., Voskuyl, A.E., 2006. Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus. Arthritis Res. Ther. 8, R183.
13. Cao, W., Bobryshev, Y.V., Lord, R.S., Oakley, R.E., Lee, S.H., Lu, J., 2003. Dendritic cells in the arterialwall express C1q: potential significance in atherogenesis. Cardiovasc. Res. 60, 175-186.
14. Carroll, M.C., 2004. The complement systemin regulation of adaptive immunity.Nat. Immunol. 5, 981-986.
15. Casciola-Rosen, L.A., Anhalt, G., Rosen, A., 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317-1330.
16. Castellano, G., Woltman, A.M., Nauta, A.J., Roos, A., Trouw, L.A., Seelen, M.A., Schena, F.P., Daha, M.R., van Kooten, C., 2004.Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood 103, 3813-3820.
17. Castellano, G., Woltman, A.M., Schlagwein, N., Xu, W., Schena, F.P., Daha, M.R., van Kooten, C., 2007. Immune modulation of human dendritic cells by complement. Eur. J. Immunol. 37, 2803-2811.
18. Csomor, E., Bajtay, Z., Sandor, N., Kristof, K., Arlaud, G.J., Thiel, S., Erdei, A., 2007. Complement protein C1q induces maturation of human dendritic cells. Mol. Immunol. 44, 3389-3397.
19. Cutler, A.J., Botto, M., van, E.D., Rivi, R., Davies, K.A., Gray, D., Walport, M.J., 1998. T cell-dependent immune response in C1q-deficient mice: defective interferon gamma production by antigen-specific T cells. J. Exp. Med. 187, 1789-1797.
20. de Saint-Vis, B., Vincent, J., Vandenabeele, S., Vanbervliet, B., Pin, J.J., Ait-Yahia, S., Patel, S., Mattei, M.G., Banchereau, J., Zurawski, S., Davoust, J., Caux, C., Lebecque, S., 1998. A novel lysosome-associated membrane glycoprotein, DCLAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9, 325-336.
21. Dempsey, P.W., Allison, M.E., Akkaraju, S., Goodnow, C.C., Fearon, D.T., 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348-350.
22. Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Gunther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., Okada, T., Vermi, W., Winkels, G., Yamamoto, T., Zysk, M., Yamaguchi, Y., Schmitz, J., 2001. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194, 1823-1834.
23. Figdor, C.G., van Kooyk, Y., Adema, G.J., 2002. C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol. 2, 77-84.
24. Fiore, N., Castellano, G., Blasi, A., Capobianco, C., Loverre, A., Montinaro, V., Netti, S., Torres, D., Manno, C., Grandaliano, G., Ranieri, E., Schena, F.P., Gesualdo, L., 2008. Immaturemyeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol. Immunol. 45, 259-265.
25. Fraser, D.A., Arora, M., Bohlson, S.S., Lozano, E., Tenner, A.J., 2007. Generation of inhibitory NFkappaB complexes and phosphorylated cAMP response elementbinding protein correlates with the anti-inflammatory activity of complement protein C1q in human monocytes. J. Biol. Chem. 282, 7360-7367.
26. Fraser, D.A., Bohlson, S.S., Jasinskiene, N., Rawal, N., Palmarini, G., Ruiz, S., Rochford, R., Tenner, A.J., 2006. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J. Leukoc. Biol. 80, 107-116.
27. Gelderman, K.A., Lam, S., Sier, C.F., Gorter, A., 2006. Cross-linking tumor cells with effector cells via CD55 with a bispecific mAb induces beta-glucan-dependent CR3-dependent cellular cytotoxicity. Eur. J. Immunol. 36, 977-984.
28. Gelderman, K.A., Tomlinson, S., Ross, G.D., Gorter, A., 2004. Complement function in mAb-mediated cancer immunotherapy. Trends Immunol. 25, 158-164.
29. Gerritsma, J.S.J., van Kooten, C., Gerritsen, A.F., van Es, L.A., Daha, M.R., 1998. TGF-β1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int. 53, 609-616.
30. Gordon, S., Taylor, P.R., 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
31. Granucci, F., Vizzardelli, C., Virzi, E., Rescigno, M., Ricciardi-Castagnoli, P., 2001. Transcriptional reprogramming of dendritic cells by differentiation stimuli. Eur. J. Immunol. 31, 2539-2546.
32. Groeneveld, T.W., Oroszlan, M., Owens, R.T., Faber-Krol, M.C., Bakker, A.C., Arlaud, G.J., McQuillan, D.J., Kishore, U., Daha, M.R., Roos, A., 2005. Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins. J. Immunol. 175, 4715-4723.
33. Heeger, P.S., Lalli, P.N., Lin, F., Valujskikh, A., Liu, J., Muqim, N., Xu, Y., Medof, M.E., 2005. Decay-accelerating factor modulates induction of T cell immunity. J. Exp. Med. 201, 1523-1530.
34. Hogasen, A.K., Wurzner, R., Abrahamsen, T.G., Dierich, M.P., 1995. Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, whichmay be released on stimulation. J. Immunol. 154, 4734-4740.
35. Kapsenberg, M.L., 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3, 984-993.
36. Karp, C.L., 1999. Measles: immunosuppression, interleukin-12, and complement receptors. Immunol. Rev. 168, 91-101.
37. Kemper, C., Atkinson, J.P., 2007. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 7, 9-18.
38. Kirchhoff, K., Weinmann, O., Zwirner, J., Begemann, G., Gotze, O., Kapp, A., Werfel, T., 2001. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin. Immunology 103, 210-217.
39. Kishore, U., Reid, K.B., 2000. C1q: structure, function, and receptors. Immunopharmacology 49, 159-170.
40. Korb, L.C., Ahearn, J.M., 1997. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158, 4525-4528.
41. Krauss, J.C., Poo H, Xue, W., Mayo-Bond, L., Todd III, R.F., Petty, H.R., 1994. Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3. J. Immunol. 153, 1769-1777.
42. Kruger, T., Benke, D., Eitner, F., Lang, A., Wirtz, M., Hamilton-Williams, E.E., Engel, D., Giese, B., Muller-Newen, G., Floege, J., Kurts, C., 2004. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J. Am. Soc. Nephrol. 15, 613-621.
43. Kurita-Taniguchi, M., Fukui, A., Hazeki, K., Hirano, A., Tsuji, S., Matsumoto, M., Watanabe, M., Ueda, S., Seya, T., 2000. Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46. J. Immunol. 165, 5143-5152.
44. Laufer, J., Katz, Y., Passwell, J.H., 2001. Extrahepatic synthesis ofcomplement proteins in inflammation. Mol. Immunol. 38, 221-229.
45. Le Naour, F., Hohenkirk, L., Grolleau, A., Misek, D.E., Lescure, P., Geiger, J.D., Hanash, S., Beretta, L., 2001. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 276, 17920-17931.
46. Lu, J., Wu, X., Teh, B.K., 2007. The regulatory roles of C1q. Immunobiology 212, 245-252.
47. Manderson, A.P., Botto, M., Walport, M.J., 2004. The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22, 431-456.
48. Marshak-Rothstein, A., 2006. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6, 823-835.
49. Medzhitov, R., Janeway Jr., C., 2000. Innate immunity. N. Engl. J. Med. 343, 338-344.
50. Mevorach, D., Mascarenhas, J.O., Gershov, D., Elkon, K.B., 1998. Complementdependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188, 2313-2320.
51. Morelli, A.E., Larregina, A.T., Shufesky, W.J., Zahorchak, A.F., Logar, A.J., Papworth, G.D., Wang, Z., Watkins, S.C., Falo Jr., L.D., Thomson, A.W., 2003. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence oncomplement receptors and effect on cytokine production. Blood 101, 611-620.
52. Morgan, B.P., Gasque, P., 1997. Extrahepatic complement biosynthesis: where, when and why? Clin. Exp. Immunol. 107, 1-7.
53. Muller, W., Hanauske-Abel, H., Loos, M., 1978. Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages: evidence for an independent production of the C1 subunits. J. Immunol. 121, 1578-1584.
54. Nauta, A.J., Castellano, G., Xu, W., Woltman, A.M., Borrias, M.C., Daha, M.R., van Kooten, C., Roos, A., 2004. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J. Immunol. 173, 3044-3050.
55. Nauta, A.J., Raaschou-Jensen, N., Roos, A., Daha, M.R., Madsen, H.O., Borrias-Essers, M.C., Ryder, L.P., Koch, C., Garred, P., 2003. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur. J. Immunol. 33, 2853-2863.
56. Nauta, A.J., Trouw, L.A., Daha, M.R., Tijsma, O., Nieuwland, R., Schwaeble, W.J., Gingras, A.R., Mantovani, A., Hack, E.C., Roos, A., 2002. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur. J. Immunol. 32, 1726-1736.
57. Navratil, J.S., Watkins, S.C., Wisnieski, J.J., Ahearn, J.M., 2001. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J. Immunol. 166, 3231-3239.
58. Ogden, C.A., deCathelineau, A., Hoffmann, P.R., Bratton, D., Ghebrehiwet, B., Fadok, V.A., Henson, P.M., 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194, 781-795.
59. Peng, Q., Li, K., Anderson, K., Farrar, C.A., Lu, B., Smith, R.A., Sacks, S.H., Zhou, W., 2008. Local production and activation ofcomplement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 111, 2452-2461.
60. Peng, Q., Li, K., Patel, H., Sacks, S.H., Zhou, W., 2006. Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J. Immunol. 176, 3330-3341.
61. Petry, F., Botto, M., Holtappels, R., Walport, M.J., Loos, M., 2001. Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells. J. Immunol. 167, 4033-4037.
62. Pickering, M.C., Cook, H.T., Warren, J., Bygrave, A.E., Moss, J., Walport, M.J., Botto, M., 2002. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 31, 424-428.
63. Porter, J.C., Hogg, N., 1998. Integrins take partners: cross-talk between integrins and other membrane receptors. Trends Cell Biol. 8, 390-396.
64. Pratt, J.R., Basheer, S.A., Sacks, S.H., 2002. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 8, 582-587.
65. Reis E Sousa, C., 2006. Dendritic cells in amature age.Nat. Rev. Immunol. 6, 476-483.
66. Reis, E.S., Barbuto, J.A., Isaac, L., 2006. Human monocyte-derived dendritic cells are a source of several complement proteins. Inflamm. Res. 55, 179-184.
67. Reis, E.S., Barbuto, J.A., Isaac, L., 2007. Complement components, regulators and receptors are produced by human monocyte-derived dendritic cells. Immunobiology 212, 151-157.
68. Reis, E.S., Barbuto, J.A., Kohl, J., Isaac, L., 2008. Impaired dendritic cell differentiation and maturation in the absence of C3. Mol. Immunol. 45, 1952-1962.
69. Sacks, S., Zhou, W., 2008. New boundaries for complement in renal disease. J. Am. Soc. Nephrol.
70. Schlaf, G., Demberg, T., Beisel, N., Schieferdecker, H.L., Gotze, O., 2001. Expression and regulation of complement factors H and I in rat and human cells: some critical notes. Mol. Immunol. 38, 231-239.
71. Schwaeble, W., Schafer, M.K., Petry, F., Fink, T., Knebel, D., Weihe, E., Loos, M., 1995. Follicular dendritic cells, interdigitating cells, and cells of the monocytemacrophage lineage are the C1q-producing sources in the spleen. Identification of specific cell types by in situ hybridization and immunohistochemical analysis. J. Immunol. 155, 4971-4978.
72. Shortman, K., Liu, Y.J., 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151-161.
73. Sjoberg, A., Onnerfjord, P., Morgelin, M., Heinegard, D., Blom, A.M., 2005. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J. Biol. Chem. 280, 32301-32308.
74. Sohn, J.H., Bora, P.S., Suk, H.J., Molina, H., Kaplan, H.J., Bora, N.S., 2003. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat. Med. 9, 206-212.
75. Soos, T.J., Sims, T.N., Barisoni, L., Lin, K., Littman, D.R., Dustin, M.L., Nelson, P.J., 2006. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int. 70, 591-596.
76. Soruri, A., Kiafard, Z., Dettmer, C., Riggert, J., Kohl, J., Zwirner, J., 2003. IL-4 downregulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo. J. Immunol. 170, 3306-3314.
77. Spirig, R., van Kooten, C., Obregon, C., Nicod, L., Daha, M., Rieben, R., in press. The endothelial protectant and complement inhibitor lowmolecularweight dextran sulfate inhibits toll-like receptor 4 induced phenotypic and functional maturation of human dendritic cells. J. Immunol.
78. Steinman, R.M., Banchereau, J., 2007. Taking dendritic cells into medicine. Nature 449, 419-426.
79. Steinman, R.M., Hawiger, D., Nussenzweig, M.C., 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711.
80. Strainic, M.G., Liu, J., Huang, D., An, F., Lalli, P.N., Muqim, N., Shapiro, V.S., Dubyak, G.R., Heeger, P.S., Medof, M.E., 2008. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28, 425-435.
81. Stuart, L.M., Takahashi, K., Shi, L., Savill, J., Ezekowitz, R.A., 2005. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J. Immunol. 174, 3220-3226.
82. Takahara, M., Kang, K., Liu, L., Yoshida, Y., McCormick, T.S., Cooper, K.D., 2003. iC3b arrestsmonocytic cell differentiation into CD1c-expressing dendritic cell precursors: a mechanism for transiently decreased dendritic cells in vivo after human skin injury by ultraviolet B. J. Invest. Dermatol. 120, 802-809.
83. Trouw, L.A., Nilsson, S.C., Goncalves, I., Landberg, G., Blom, A.M., 2005. C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med. 201, 1937-1948.
84. Tsan, M.F., Gao, B., 2004. Endogenous ligands of toll-like receptors. J. Leukoc. Biol. 76, 514-519.
85. Tsutsumi, A., Takahashi, R., Sumida, T., 2005. Mannose binding lectin: genetics and autoimmune disease. Autoimmun. Rev. 4, 364-372.
86. Vaknin-Dembinsky, A., Murugaiyan, G., Hafler, D.A., Astier, A.L., Weiner, H.L., 2008. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J. Neuroimmunol. 195, 140-145.
87. van Kooten, C., Boonstra, J.G., Paape, M.E., Fossiez, F., Banchereau, J., Lebecque, S., Bruijn, J.A., De Fijter, J.W., van Es, L.A., Daha, M.R., 1998. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J. Am. Soc. Nephrol. 9, 1526-1534.
88. Vegh, Z., Goyarts, E.C., Rozengarten, K., Mazumder, A., Ghebrehiwet, B., 2003. Maturation-dependent expression of C1q-binding proteins on the cell surface of human monocyte-derived dendritic cells. Int. Immunopharmacol. 3, 345-357.
89. Vegh, Z., Kew, R.R., Gruber, B.L., Ghebrehiwet, B., 2006. Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR. Mol. Immunol. 43, 1402-1407.
90. Verbovetski, I., Bychkov, H., Trahtemberg, U., Shapira, I., Hareuveni, M., Ben-Tal, O., Kutikov, I., Gill, O., Mevorach, D., 2002. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 196, 1553-1561.
91. Verschoor, A., Brockman, M.A., Gadjeva, M., Knipe, D.M., Carroll, M.C., 2003. Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J. Immunol. 171, 5363-5371.
92. Waggoner, S.N., Cruise, M.W., Kassel, R., Hahn, Y.S., 2005. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J. Immunol. 175, 4706-4714.
93. Walker, D.G., 1998. Expression and regulation of complement C1q by human THP-1-derived macrophages. Mol. Chem. Neuropathol. 34, 197-218.
94. Walport, M.J., 2001a.Complement. First of two parts.N. Engl. J.Med. 344, 1058-1066.
95. Walport, M.J., 2001b. Complement. Second of two parts. N. Engl. J. Med. 344, 1140-1144.
96. Woltman, A.M., De Fijter, J.W., Zuidwijk, K., Vlug, A.G., Bajema, I.M., Van der Kooij, S.W., van Ham, V., van Kooten, C., 2007. Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int. 71, 1001-1008.
97. Woltman, A.M., Van der Kooij, S.W., De Fijter, J.W., van Kooten, C., 2006. Maturationresistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA+ and CD45RO+ T-cell populations. Am. J. Transplant. 6, 2580-2591.
98. Wood, K.J., Sawitzki, B., 2006. Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol. 27, 183-187.
99. Xu, W., Berger, S.P., Trouw, L.A., de Boer, H.C., Schlagwein, N., Mutsaers, C., Daha, M.R., van Kooten, C., 2008. Properdin binds to late apoptotic and necrotic cells independently of c3b and regulates alternative pathway complement activation. J. Immunol. 180, 7613-7621.
100. Xu, W., Roos, A., Schlagwein, N., Woltman, A.M., Daha, M.R., van Kooten, C., 2006. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107, 4930-4937.
101. Yamada, M., Oritani, K., Kaisho, T., Ishikawa, J., Yoshida, H., Takahashi, I., Kawamoto, S., Ishida, N., Ujiie, H., Masaie, H., Botto, M., Tomiyama, Y., Matsuzawa, Y., 2004. Complement C1q regulates LPS-induced cytokine production in bone marrowderived dendritic cells. Eur. J. Immunol. 34, 221-230.
102. Zhou, W., Patel, H., Li, K., Peng, Q., Villiers, M.B., Sacks, S.H., 2006.Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 107, 2461-2469.
103. Zhou, W., Peng, Q., Li, K., Sacks, S.H., 2007. Role of dendritic cell synthesis of complement in the allospecific T cell response. Mol. Immunol. 44, 57-63.